Discovery may lead to development of safer immunosuppressants

Thursday, March 12, 2009 - 13:14 in Health & Medicine

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases. However, currently available immunosuppressant drugs can pose serious health risks, restricting their long-term use. Now, new research findings may lead to the development of immunosuppressant drugs that have fewer adverse side effects. The study, published by Cell Press in the March 13th issue of the journal Molecular Cell, reveals detailed information about how drugs commonly used to prevent transplant rejection interact with their target.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net